ARWR - Arrowhead Pharmaceuticals GAAP EPS of -$1.92 misses by $0.41 revenue of $240.73M misses by $22.85M
2023-11-29 16:04:27 ET
More on Arrowhead Pharmaceuticals
- Arrowhead Pharmaceuticals: A High-Risk, High-Reward Bet
- Arrowhead Pharmaceuticals Q4 2023 Earnings Preview
- GSK inks $1B deal to obtain rights to hepatitis B drug from J&J
- Seeking Alpha’s Quant Rating on Arrowhead Pharmaceuticals
- Historical earnings data for Arrowhead Pharmaceuticals
For further details see:
Arrowhead Pharmaceuticals GAAP EPS of -$1.92 misses by $0.41, revenue of $240.73M misses by $22.85M